MedPath

Effect of synbiotic in diabetes

Phase 2
Conditions
type1 Diabetes.
Type 1 diabetes mellitus
Registration Number
IRCT20180310039020N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

All of type 1 diabetes who have at least 1 year of diagnosis
?According to BMI for age chart, their body mass index is below 95%

Exclusion Criteria

Unwillingness of patients to participate in the study
Renal diseases, coronary arteries, acute and chronic inflammation of the lungs, short stomach cyst syndrome, allergies, pregnancy, lactation
Traveling for more than 2 weeks
Smokers, the use of food supplements, anti-inflammatory drugs, the use of any antioxidant supplements in the last 3 months, the use of immunosuppressive drugs
Follow certain diets, change your diet or decide to lose weight

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath